Kestrel

Cloud-Based Scientific Literature Content and Management Platform

Cell & Gene Therapy Catapult · published Mon 21 Sep 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

The notice doesn't say where the documents are, but Cell & Gene Therapy Catapult's other tenders use Delta eSourcing. Register there (it's free) and look for this tender, or email the buyer's contact on the notice.

The notice as published

The CGTC requires a cloud-based scientific literature content and management platform (‘the platform’). The platform aims to provide all Cell and Gene Therapy Catapult staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory content. The contract will be for a one-year period, with the option to extend for two further one-year periods (1+1+1).